Skip to content
Latest
Jamie Dimon Hated Bitcoin: JPMorgan Now Expects BTC to Beat Stocks and Gold Kevin Hassett says US-Canada trade negotiations are gaining momentum AI Just Put a $5 Million-a-Day Price Tag on Its Biggest Bottleneck Elon Musk faces Republican criticism over restrictions on Ukraine’s Starlink access Stablecoin deposits in DeFi rise 560.8% in three years as lending pools log outflows Goldman Sachs Cuts Its Price Target for South Korea’s KOSPI CoinDCX Admits $16M Loss Just Days After CEO Denied Fresh Wallet Breach CoinDCX confirms $16 million loss from retired wallets days after CEO called breach reports a ‘false alarm’ Jamie Dimon Hated Bitcoin: JPMorgan Now Expects BTC to Beat Stocks and Gold Kevin Hassett says US-Canada trade negotiations are gaining momentum AI Just Put a $5 Million-a-Day Price Tag on Its Biggest Bottleneck Elon Musk faces Republican criticism over restrictions on Ukraine’s Starlink access Stablecoin deposits in DeFi rise 560.8% in three years as lending pools log outflows Goldman Sachs Cuts Its Price Target for South Korea’s KOSPI CoinDCX Admits $16M Loss Just Days After CEO Denied Fresh Wallet Breach CoinDCX confirms $16 million loss from retired wallets days after CEO called breach reports a ‘false alarm’
STOX.NEWS
In focus
BTC 24 TLDR 16 JST 9 NXTT 8 POST 6 XRP 4 TGT 4 ETH 4

Moderna’s cancer vaccine is ‘likely’ to get approved. Skeptics question if it will be the best option.

MarketWatch
Image supplied by MarketWatch.
Advertisement
Demo creative for ADG7 Article top (728x90)

The first Phase 3 data for a custom cancer vaccine has raised questions about whether the potential new treatment is needed.

Related video

Advertisement
Demo creative for ADG8 Article body (336x280)

Companies named

More on this

Advertisement
Demo creative for ADG3 Footer banner (728x90)